Chinese Herbal Medicine Promising for HCV Treatment
the MPR take:
A compound extracted from a herb found in certain regions of Taiwan and Southern China has shown to inhibit the hepatitis C virus (HCV) at multiple stages of the viral lifecycle. Research presented at the International Liver Congress 2014 showed that the compound, called SBEL1, reduced HCV protein in cells treated prior to infection by 23%. Liver cells transfected with an HCV internal ribosome entry site (IRES)-driven luciferase reporter saw a reduction in reporter activity by 50%, and the HCV ribonucleic acid (RNA) levels were lowered by 78% in HCV infected cells treated with SBEL1. These findings suggest that SBEL1 may be an effective treatment to halt HCV viral protein production.
READ FULL ARTICLE From virtualpressoffice.easl.eu